While the combination is sometimes advertised on internet pharmacies, it is not licensed by the MHRA. Purchasing unapproved medicines online carries risks of counterfeit products, incorrect dosing, and lack of medical oversight.
Dapoxetine has a short half-life of roughly 1-2 hours, with clinical effects on ejaculatory control typically lasting 3-6 hours after ingestion.
Sildenafil can lower blood pressure, so concurrent use with certain antihypertensives (especially alpha-blockers) may cause additive hypotension. Blood pressure should be monitored, and dosage adjustments made by a prescriber if needed.
This is a medical emergency known as priapism. Seek immediate emergency care; prompt treatment reduces the risk of permanent penile damage.
A high-fat meal can delay the onset of sildenafil’s effect by up to an hour. Taking the tablet with a light meal or on an empty stomach may provide faster results.
Alcohol can enhance the blood-pressure-lowering effect of sildenafil and may increase the chance of dizziness or reduced erection quality. Moderation is advised.
Pharmacologically the active ingredients are identical, but the fixed-dose combination has not undergone the same rigorous safety testing as the individually licensed products. Individual dosing flexibility is lost when using a combination tablet.
Importing unlicensed medicines into the UK may breach customs regulations and expose the user to unregulated products. The MHRA advises against importing medicines that are not approved for UK use.
Keep the pill in its original packaging, protected from heat, humidity, and direct sunlight. Avoid leaving it in a car or luggage exposed to extreme temperatures.
Neither sildenafil nor dapoxetine is known to cause physical dependence. Psychological reliance on medication for sexual performance can occur, and patients should discuss any concerns with their healthcare provider.
Super Kamagra is a combination pill that contains two active ingredients: sildenafil (100 mg) and dapoxetine (60 mg). Both components are prescription-only medicines (POM) in the United Kingdom and belong to different therapeutic classes. Sildenafil is a phosphodiesterase-type 5 (PDE5) inhibitor used to improve erectile function, while dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) approved for the treatment of premature ejaculation.
The combination is not licensed by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and therefore is considered an off-label product. It is sometimes marketed as a “dual-action” solution for men who experience both erectile dysfunction (ED) and premature ejaculation (PE), but no formal evaluation of the combination’s safety or efficacy has been published by regulatory authorities.
When taken together, the two agents aim to address two separate physiological processes: penile vascular insufficiency (via sildenafil) and ejaculatory control (via dapoxetine).
| Ingredient | UK-Approved Indication(s) | ||| | Sildenafil | Treatment of erectile dysfunction in adult men (MHRA-approved as a prescription-only product). | | Dapoxetine | Management of premature ejaculation in adult men (licensed as Priligy®; prescription-only). |
Because the Super Kamagra combination itself has not received MHRA approval, it does not have an official indication. Clinicians may prescribe the individual components separately when both conditions need treatment, but they must do so under separate product licences.
The fixed-dose combination of sildenafil 100 mg with dapoxetine 60 mg has limited peer-reviewed data. Small case series and anecdotal reports describe its use for men who experience concurrent ED and PE, but the evidence does not meet the standards required for regulatory endorsement.
Disclaimer: Off-label use requires individualized risk assessment and close monitoring for adverse effects.
Absolute contraindications
Relative contraindications / cautions
Special populations
If any of the above conditions apply, a healthcare professional should evaluate the suitability of Super Kamagra on a case-by-case basis.
Most of these effects are dose-related and improve with continued use or dose adjustment.
Any of these events should prompt immediate medical evaluation.
Major interactions
Nitrates (e.g., nitroglycerin) → profound hypotension.
CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) → increased sildenafil concentrations, heightening risk of hypotension and visual disturbances.
Moderate interactions
CYP3A4 inducers (e.g., rifampicin, carbamazepine) → reduced sildenafil efficacy.
Other SSRIs or serotonergic agents (e.g., fluoxetine, tramadol) → elevated risk of serotonin syndrome when combined with dapoxetine.
Minor interactions
Alpha-blockers (e.g., tamsulosin) → additive blood-pressure-lowering effect; monitor for dizziness.
Patients should provide a complete medication list, including over-the-counter products and herbal supplements, before starting Super Kamagra.
Special dosing considerations
All dosing decisions should be individualized by a prescriber.
Routine laboratory testing is not required for most patients, but liver and kidney function tests may be indicated for those with existing organ impairment.
This article provides educational information about Super Kamagra and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.